So far this year, Amplion has tracked 67 Seed and Series A investments into early-stage biotechs – down from 92 or a 27% decrease during the same period last year. That said, the biotech sector continues to witness rapid advancements, with numerous early-stage...
Amplion Lead Generation and Prospecting: A Guide for Life Science Sales and Marketing Teams In this guide, you’ll learn ways to master: Identifying your ideal accounts Finding new and emerging accounts Learning your key account’s story Connecting with...
Life science commercial teams spend a lot of time trying to find the right customers. Ever wonder why that is? Nah. You know it’s because finding the right contacts—those directly associated with research or drug development programs aligned to your products and...
So you’ve secured a meeting with a prospect from one of your top-tier pharma, biopharma, or academia target organizations. Excited? For sure. But you still have a lot to do to prepare. Research, Research, and, Hey, Did We Mention Research? The first step in preparing...
Selling into early-stage research and clinical programs is critical to having your technology, products, or services embedded in a new disease or drug program. Still, unless you have all the right connections at thousands of organizations (or a crystal ball!),...
Traditional lead gen is poorly suited to Life Science marketing and sales Traditional marketing approaches rely heavily on generating a large number of marketing leads, then spending months executing nurturing campaigns with broad reach and spend. Once these campaigns...
